Randomized phase I/II clinical trial of a melanoma helper peptide vaccine with or without systemic agonistic anti-CD27 antibody (varlilumab).

varlilumab (CDX 1127) - Celldex

http://www.ncbi.nlm.nih.gov/pubmed/41960901

Andrew S Poklepovic; Craig L Slingluff; David Brighton; Elizabeth Gaughan; Emily K Ninmer; Gina R Petroni; Jack A Engel; Jennifer L Bryant; Kathleen Haden; Kelly T Smith; Kimberly A Chianese-Bullock; Paul Wright; Timothy N J Bullock; Varinder Kaur

Apr 11, 2026